One of the most common concerns about testosterone-boosting supplements is whether stopping them will crash your levels below where you started. The fear is that your body becomes dependent and your natural production is permanently impaired. For compounds that boost endogenous production rather than replacing it, the evidence is reassuring.
The Clomiphene Discontinuation Data
The most relevant clinical data comes from clomiphene citrate studies. Clomiphene is a selective estrogen receptor modulator that significantly elevates testosterone by stimulating the HPTA axis. When subjects discontinued clomiphene after extended use, testosterone levels dropped from their elevated treatment levels but remained slightly above pre-treatment baseline at the 90-day follow-up mark.
This is the opposite of a crash. Rather than suppressing endogenous production, the period of enhanced HPTA stimulation appeared to provide a modest lasting benefit. The mechanism may involve upregulation of LH receptor sensitivity or improved hypothalamic signaling efficiency that persists after the exogenous stimulus is removed.
Why This Differs From Exogenous Testosterone
The critical distinction is between compounds that stimulate your own production and compounds that replace it. Exogenous testosterone provides the hormone directly, causing the feedback loop to suppress LH, FSH, and GnRH. The testes reduce production because they are no longer needed. Upon cessation, the suppressed axis must recover, which takes weeks to months and may be incomplete after prolonged use.
Compounds that work upstream of testosterone production, like SERMs (clomiphene, enclomiphene), do not create this suppression dynamic. They stimulate the signaling cascade rather than bypassing it. The testes remain active throughout treatment because they are the ones producing the elevated testosterone. When the stimulus is removed, they continue functioning at their baseline capacity. This is a fundamental principle of the Tony Huge Laws of Biochemistry Physics: stimulating an endogenous pathway does not inherently damage its baseline function, whereas replacing its end product often does.
Natural Herbal Testosterone Boosters
For natural testosterone boosters like ashwagandha, tongkat ali, and fadogia agrestis, the discontinuation profile is even more benign. These compounds operate through mild, indirect mechanisms: stress reduction, adaptogenic effects, or marginal enhancements to steroidogenic enzyme activity. They do not produce hormonal changes dramatic enough to meaningfully alter feedback signaling.
Discontinuing herbal testosterone boosters typically results in a return to baseline within days to weeks, with no rebound suppression. The physiological impact is too mild to create dependence or withdrawal effects.
The General Principle
If a compound works by enhancing your body’s own hormonal production without suppressing the feedback loop, discontinuation should return you to baseline or slightly above it. If a compound works by introducing exogenous hormones that suppress your feedback loop, discontinuation carries the risk of a crash below baseline. Understanding which category a compound falls into is essential information before starting any hormonal optimization protocol.
Interesting Perspectives
While clinical data on discontinuation is limited, some unconventional viewpoints exist. Anecdotal reports from biohackers suggest that cycling off certain natural boosters like tongkat ali after prolonged use can sometimes lead to a perceived “flat” period, not from hormonal suppression but from the removal of adaptogenic support for cortisol and mood. This isn’t a crash, but a re-acclimation to baseline stress physiology. Furthermore, the concept of “HPTA priming” is debated—some practitioners argue that a period of enhanced signaling with a SERM like enclomiphene could potentially “reset” a slightly sluggish axis to a more responsive state, explaining the slight elevation above baseline seen in some studies. This aligns with the broader biohacking principle of using transient stimulation to improve long-term system function, rather than creating permanent external dependency.
Citations & References
- Guay AT, et al. Clomiphene increases free testosterone levels in men with both secondary hypogonadism and erectile dysfunction: who does and does not benefit? Int J Impot Res. 2003.
- Wiehle RD, et al. Enclomiphene citrate stimulates testosterone production while preventing oligospermia: a dose response study in hypogonadal men. J Urol. 2014.
- Shabsigh A, et al. Clomiphene citrate and enclomiphene for the treatment of hypogonadal androgen deficiency. Expert Opin Investig Drugs. 2009.
- Helo S, et al. A randomized prospective double-blind comparison trial of clomiphene citrate and anastrozole in raising testosterone in hypogonadal infertile men. J Sex Med. 2015.
- Moskovic DJ, et al. Clomiphene citrate is safe and effective for long-term management of hypogonadism. BJU Int. 2012.